The George Clinical statistics department operates globally to provide data and expertise that will enable faster, more informed decisions with reliable and flexible service. The statistics team works closely with the data management team to render an integrated and seamless data solution. Our services are flexible to cater to full-service studies or a strategic bespoke solution aligned to client organization needs.
The biostatistics team has extensive experience in the design and analysis of clinical trials in a wide range of therapeutic areas.
Solutions are tailored to customers’ requirements include Phase I – IV Clinical Trials, Late Phase / Real World studies, Regulatory Submissions, as well as complex surveys and longitudinal studies.
We support clinical trials and other research projects from conception to publication. All the analyses use up-to-date and validated software (e.g. SAS and Stata for statistical analyses, PASS for sample size calculations, and nQuery) and are performed to ICH GCP standards with emphasis on validation, traceability and reproducibility.
George Clinical’s statistics experts analyze and design clinical trials across a broad range of therapeutic areas, including, but not limited to: Oncology, Cardiology, Neurology, Respiratory, Nephrology, Endocrinology, Pain Control, Infectious Diseases, Critical Care, Substance Abuse and a diversity of Medical Devices.
To see the breadth of our networks in each therapeutic area, please click on the below links:
George Clinical biostatistics department’s key outputs include:
